[11] |
Kim K,Lee JH.Risk factors and biomarkers of ischemic stroke in cancer patients[J].Stroke,2014,16(2):91-96.
|
[4] |
赫丹丹,李永男,刘丽娜,等.急性脑梗塞后肺部感染的相关因素及预后[J].现代生物医学进展,2012,12(20):3860-3863.
|
[5] |
张伟,唐萍,罗芳.脑血栓患者医院感染性肺炎病原菌分布与药敏分析[J].中华医院感染学杂志,2015,25(4):783-785.
|
[6] |
李荣华,李霞,马秋华.房颤患者肺炎衣原体感染的相关因素分析及临床诊治[J].中华医院感染学杂志,2013,23(19):4632-4634.
|
[8] |
Wang DZ,Chen W,Yang S,et al.Helicobacter pylori infection in Chinese patients with atrial fibrillation[J].Clin Interv Aging,2014,10:813-819.
|
[1] |
Oluleye OW,Rector TS,Win S,et al.History of atrial fibrillation as a risk factor in patients with heart failure and preserved ejection fraction[J].Circ Heart Failure,2014,7(6):960-966.
|
[2] |
Reinecke H,Engelbertz C,Sch覿bitz WR.Preventing stroke in patients with chronic kidney disease and atrial fibrillation:benefit and risks of old and new oral anticoagulants[J].Stroke,2013,44(10):2935-2941.
|
[3] |
Taina M,Sipola P,Muuronen A,et al.Determinants of left atrial appendage volume in stroke patients without chronic atrial fibrillation[J].PLos One,2014,9(3):E90903.
|
[7] |
Kim JY,Lee SJ,Kim JH,et al.Effects of atrial fibrillation on the outcome of the rehabilitation in patients with cerebral Infarction[J].Ann Rehabil Med,2014,38(6):766-774.
|
[9] |
Deitelzweig SB,Buysman E,Pinsky B,et al.Warfarin use and stroke risk among patients with nonvalvular atrial fibrillation in a large managed care population[J].Clin Ther,2013,35(8):1201-1210.
|
[10] |
Chang TY,Chao TF,Liu CJ,et al.The association between influenzainfection,vaccination,andatrialfibrillation:a nationwide case-control study[J].Heart Rhythm Soc,2016,13(6):1189-1194..
|
[12] |
Simonyi G,Medvegy M.Rivaroxaban in prevention of stroke in patients with atrial fibrillation[J].Ideggyogy SZ,2012,65(11-12):365-368.
|
[13] |
Zeng Q,Tao W,Lei C,et al.Etiology and risk factors of posterior circulation infarction compared with anterior circulation infarction[J].J Stroke Cerebrovasc Dis,2015,24(7):1614-1620.
|